MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Dermatology

  • Home
  • Specialties
  • Dermatology
  • Page 8
Rapid Initial Benefits of Secukinumab in Early Psoriatic Arthritis: Insights from a Treat-to-Target Randomized Trial
Posted inClinical Updates Dermatology news Specialties

Rapid Initial Benefits of Secukinumab in Early Psoriatic Arthritis: Insights from a Treat-to-Target Randomized Trial

Posted by By MedXY 07/31/2025
Early secukinumab use in newly diagnosed psoriatic arthritis delivers faster clinical improvement at 3 months compared to standard care, but this advantage diminishes by 6 months and beyond.
Read More
JAK Inhibitors and Venous Thromboembolism in Atopic Dermatitis: Clinical Risks and Practice Implications
Posted inClinical Updates Dermatology news Specialties

JAK Inhibitors and Venous Thromboembolism in Atopic Dermatitis: Clinical Risks and Practice Implications

Posted by By MedXY 07/30/2025
JAK inhibitors significantly increase the risk of venous thromboembolism compared to dupilumab and methotrexate in atopic dermatitis, underscoring the need for individualized risk stratification.
Read More
FDA Fast-Tracks Rezpegaldesleukin for Severe Alopecia Areata: Promise for a Challenging Disease
Posted inClinical Updates Dermatology news Specialties

FDA Fast-Tracks Rezpegaldesleukin for Severe Alopecia Areata: Promise for a Challenging Disease

Posted by By MedXY 07/30/2025
The FDA has granted Fast Track status to rezpegaldesleukin (REZPEG), a novel biologic targeting regulatory T cells, for severe-to-very severe alopecia areata in patients aged ≥12 years. Phase 2b trial results are anticipated in December 2025.
Read More
JAK Inhibitors and Thromboembolic Risk in Atopic Dermatitis: A Comparative Safety Signal
Posted inClinical Updates Dermatology Specialties

JAK Inhibitors and Thromboembolic Risk in Atopic Dermatitis: A Comparative Safety Signal

Posted by By MedXY 07/29/2025
A large real-world cohort study finds JAK inhibitors increase risk of venous thromboembolism versus dupilumab and methotrexate in atopic dermatitis, highlighting the need for individualized therapy.
Read More
Scrotal Eczema: Understanding, Treating, and Preventing This Common Yet Distressing Condition
Posted inDermatology news

Scrotal Eczema: Understanding, Treating, and Preventing This Common Yet Distressing Condition

Posted by By MedXY 07/26/2025
Scrotal eczema causes significant discomfort but can be effectively managed with the right care. Learn about causes, treatments, and tips to prevent flare-ups.
Read More
Hair Transplantation: Is It a Permanent Solution for Hair Loss?
Posted inDermatology news Plastic Surgery

Hair Transplantation: Is It a Permanent Solution for Hair Loss?

Posted by By MedXY 07/26/2025
Exploring whether hair transplantation truly offers a permanent fix for hair loss, this article examines scientific evidence, common myths, and practical advice for those considering the procedure.
Read More
Can Hair Transplants Offer a Permanent Solution to Balding?
Posted inDermatology news

Can Hair Transplants Offer a Permanent Solution to Balding?

Posted by By MedXY 07/26/2025
Explore whether hair transplants provide a lasting solution to baldness, along with insights into prevention and treatment options.
Read More

Posts pagination

Previous page 1 … 6 7 8
  • The Laennec Technique: Advancing Standardization in Right Robotic Donor Hepatectomies
  • Assessing the Learning Curve of Robotic Left-Sided Pancreatectomy: Safety and Oncological Outcomes in a Multicenter International Study
  • Strategies to Minimize Coronary Malperfusion in Bioprosthetic Aortic Root Replacement
  • Bridging Gaps in Trauma Care: Assessing Trauma-Informed Communication in the Trauma Bay
  • Robotic Versus Laparoscopic Cholecystectomy: Balancing Safety, Efficacy, and Cost with a Novel Risk Calculator
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation ischemic stroke MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top